BRIEF published on 05/22/2025 at 11:05, 6 months 13 days ago Ateme Combined General Meeting on June 11, 2025: Preparatory Documentation Available Shareholders General Assembly Documentation ATEME Vélizy-Villacoublay
BRIEF published on 05/14/2025 at 17:50, 6 months 21 days ago Tech Day 2025: Ateme Unveils its Strategic Axes Technologies Strategy ATEME Rationalization Tech Day
BRIEF published on 04/25/2025 at 18:05, 7 months 9 days ago Ateme's 2024 Universal Registration Document Available AMF Financial Report Finance Registration Document ATEME
PRESS RELEASE published on 04/25/2025 at 18:00, 7 months 9 days ago PUBLICATION OF THE 2024 UNIVERSAL REGISTRATION DOCUMENT Ateme's 2024 Universal Registration Document approved by AMF on April 25, 2025. Document includes financial reports, corporate governance, and share buyback program details Corporate Governance Financial Reports Universal Registration Document AMF Approval ATEME
BRIEF published on 04/24/2025 at 17:50, 7 months 10 days ago ATEME: Results for the 1st Quarter of 2025 Financial Results Turnover 2027 Objectives Geographic Growth Streaming Technologies
PRESS RELEASE published on 04/24/2025 at 17:45, 7 months 10 days ago FIRST QUARTER 2025 REVENUES Ateme reports Q1 revenues of €18.4 million, up 4% (+3% like-for-like), recent NAB Show confirms outstanding reputation. Financial objectives confirmed Growth Financial Objectives ATEME NAB Show Q1 Revenues
PRESS RELEASE published on 03/19/2025 at 17:50, 8 months 16 days ago FULL YEAR 2024 RESULTS Ateme reports FY 2024 revenues of €93.5 million, down 7% YoY. Monthly recurring revenues up 20%. EBITDA at €1.1 million. Company aims for improved profitability in 2025 Revenues EBITDA Profitability 2025 ATEME
BRIEF published on 03/19/2025 at 17:50, 8 months 16 days ago Ateme's 2024 annual results: decline in turnover but encouraging outlook EBITDA Recurring Revenue Turnover Operating Expenses Outlook 2025
BRIEF published on 01/30/2025 at 17:50, 10 months 5 days ago Ateme Reports Stable Q4 2024 Revenues Amid Overall Decline Revenue Recurring Revenue Regional Performance Q4 2024 Profitability Goals
PRESS RELEASE published on 01/30/2025 at 17:45, 10 months 5 days ago FOURTH QUARTER AND FULL YEAR 2024 REVENUES Ateme posted stable 4th quarter revenues of €30.3 million in 2024, with full-year revenues at €93.5 million, down -7% and -6% like-for-like. EBITDA expected around breakeven for 2024 Revenues Financial Results EBITDA ATEME Commercial Reorganization
Published on 12/05/2025 at 02:35, 3 hours 29 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 4 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 59 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 4 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 34 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 14 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 39 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 49 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 54 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 4 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 19 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 20 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 3 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
